Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium

被引：6

作者：

Annemans, L ^{[1
]}

Crott, R ^{[1
]}

Degraeve, D ^{[1
]}

Dubois, D ^{[1
]}

Huybrechts, M ^{[1
]}

Peys, F ^{[1
]}

Robays, H ^{[1
]}

Smets, J ^{[1
]}

Tomas, M ^{[1
]}

Vanschoubroek, K ^{[1
]}

机构：

[1] BESPE, UZ Gent Cent Apotheek, PEC Secretariaat, B-9000 Ghent, Belgium

来源：

PHARMACY WORLD & SCIENCE | 2002年 / 24卷 / 01期

关键词：

Belgium; pharmaco-economic evaluation; pharmaco-economy; standard report format;

D O I：

10.1023/A:1014896830042

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pharmaco-economic evaluations become more important for the reimbursement of pharmaceuticals, and will be obligatory for new pharmaceutical drugs for which an added therapeutic value is claimed and a price premium is proposed by the manufacturer. Therefore, it is important to guide purchasers and providers of pharmaceutical care in their efforts related to the evaluation process. Standard Report Format can support the quality transparency and exhaustiveness of the data submitted. A multidisciplinary task force developed a Standard Report Format for pharmaco-economic evaluations in Belgium.

引用

页码：5 / 7

页数：3

共 5 条

[1] *BELG STAATSBL MON, 2001, PROJ LOI PORT MES MA
[2] The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
Glennie, JL
Torrance, GW
Baladi, JF
Berka, C
Hubbard, E
Menon, D
Otten, N
Rivière, M
[J]. PHARMACOECONOMICS, 1999, 15 (05) : 459 - 468
[3] Reporting format for economic evaluation - Part I: Application to the Dutch Healthcare System
Nuijten, MJC
Brorens, MJA
Hekster, YA
van der Kuy, A
Lockefeer, JHM
de Smet, PAGM
Bonsel, G
Pronk, MH
[J]. PHARMACOECONOMICS, 1998, 14 (02) : 159 - 163
[4] Developing guidance for budget impact analysis
Trueman, P
Drummond, M
Hutton, J
[J]. PHARMACOECONOMICS, 2001, 19 (06) : 609 - 621
[5] 1995, PROPOSAL METHODOLOGI

← 1 →